211 related articles for article (PubMed ID: 6671134)
1. Correlation between blood granulocyte progenitor cells and polymorphonuclear leukocytes. A tentative pathophysiological subgrouping of neutropenic and neutrophilic patients.
Ponassi A; Morra L; Mela GS; Caristo G; Parodi GB; Sacchetti C
Biomed Pharmacother; 1983; 37(6):293-7. PubMed ID: 6671134
[TBL] [Abstract][Full Text] [Related]
2. Defective CSA-dependent granulopoiesis in patients with chronic drug-induced neutropenia.
Eliopoulos G; Meletis J; Fessas P; Anagnou NP
Haematologia (Budap); 1990; 23(2):101-9. PubMed ID: 2272534
[TBL] [Abstract][Full Text] [Related]
3. Prediction of engraftment after autologous peripheral blood progenitor cell transplantation: CD34, colony-forming unit-granulocyte-macrophage, or both?
Jansen EM; Hanks SG; Terry C; Akard LP; Thompson JM; Dugan MJ; Jansen J
Transfusion; 2007 May; 47(5):817-23. PubMed ID: 17465946
[TBL] [Abstract][Full Text] [Related]
4. Growth of bone marrow CFU-GM in a case of cyclical neutropenia. Preliminary report.
Ghizzi A; De Caro L; Costa R; Berti P
Boll Soc Ital Biol Sper; 1989 Jul; 65(7):617-24. PubMed ID: 2597416
[TBL] [Abstract][Full Text] [Related]
5. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
6. Marginal neutrophil pool size in normal subjects and neutropenic patients as measured by epinephrine infusion.
Joyce RA; Boggs DR; Hasiba U; Srodes CH
J Lab Clin Med; 1976 Oct; 88(4):614-20. PubMed ID: 787457
[TBL] [Abstract][Full Text] [Related]
7. Inhibitor of granulopoiesis in human cyclic neutropenia.
Cukrová V; Klamová H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(5):647-52. PubMed ID: 1709897
[TBL] [Abstract][Full Text] [Related]
8. Impaired production of GM-CSA in bone marrow and peripheral blood monocytes in two patients with severe congenital neutropenia.
Eliopoulos G; Coulocheri S; Eliopoulos A; Vaiopoulos G; Tsantali C; Anagnou N
Haematologia (Budap); 1991; 24(2):63-70. PubMed ID: 1816056
[TBL] [Abstract][Full Text] [Related]
9. [Correlation between availability of GM progenitors and endogenous CSA production in neutropenia].
Ghizzi A; De Caro L
Boll Soc Ital Biol Sper; 1993 Sep; 69(9):541-8. PubMed ID: 8155312
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil migration in vivo and in vitro in healthy neutropenic subjects.
Koivuranta-Vaara P; Repo H
APMIS; 1988 Oct; 96(10):906-10. PubMed ID: 3190914
[TBL] [Abstract][Full Text] [Related]
11. Range and clinical significance of the number of myeloid-committed stem cells in the blood of patients with acute leukaemia in remission.
Hinterberger W; Bettelheim P; Höcker P; Lechner K; Neumann E; Niessner H
Scand J Haematol; 1984 Sep; 33(3):244-51. PubMed ID: 6505626
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte progenitor cells in peripheral blood and leucocyte CSA in patients with neutrophilic leucocytosis not due to haematological disease. A clinical study.
Morra L; Ponassi A; Gigli G; Molinari A; Sacchetti C
Haematologica; 1979 Oct; 64(5):561-9. PubMed ID: 116916
[No Abstract] [Full Text] [Related]
13. Ontogeny of the granulocyte/macrophage progenitor cell (GM-CFC) pools in the beagle.
Nothdurft W; Braasch E; Calvo W; Prümmer O; Carbonell F; Grilli G; Fliedner TM
J Embryol Exp Morphol; 1984 Apr; 80():87-103. PubMed ID: 6747533
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience.
Hassan HT; Krog C; Stockschläder M; Schleimer B; Zeller W; Krüger W; Erttmann R; Zander AR
Anticancer Res; 1997; 17(1B):589-99. PubMed ID: 9066585
[TBL] [Abstract][Full Text] [Related]
15. Effect of human cytomegalovirus on proliferation of hematopoietic progenitor cells of cord blood.
Liu WJ; Jin RM; Fu XD; Liu B; Guo QL; Deng ZH
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Apr; 8(2):85-9. PubMed ID: 16613695
[TBL] [Abstract][Full Text] [Related]
16. Antigenic characteristics of circulating granulocyte-macrophage progenitors (CFU-GM) in idiopathic myelofibrosis and polycythaemia vera defined by monoclonal antibodies.
Robak T
Arch Immunol Ther Exp (Warsz); 1989; 37(1-2):17-28. PubMed ID: 2619501
[TBL] [Abstract][Full Text] [Related]
17. [New developments in understanding the compensatory hematological reactions and their outcomes in local fractionated therapeutic gamma irradiation].
Danilova MA; Kolesnikova AI; Pavlov VV; Bogatyreva TI; Konopliannikov AG; Lepekhina LA; Kal'sina SSh; Deniskina EF
Ter Arkh; 1997; 69(7):42-6. PubMed ID: 9424757
[TBL] [Abstract][Full Text] [Related]
18. The influence of amifostine used alone or in combination with 2-chlorodeoxyadenosine on normal and chronic myelogenous leukemia granulocyte-macrophage progenitor cells in vitro.
Korycka A; Robak T
Arch Immunol Ther Exp (Warsz); 2000; 48(4):293-9. PubMed ID: 11059647
[TBL] [Abstract][Full Text] [Related]
19. Expansion in bioreactors of human progenitor populations from cord blood and mobilized peripheral blood.
Van Zant G; Rummel SA; Koller MR; Larson DB; Drubachevsky I; Palsson M; Emerson SG
Blood Cells; 1994; 20(2-3):482-90; discussion 491. PubMed ID: 7538353
[TBL] [Abstract][Full Text] [Related]
20. Comparison between diurnal changes and changes induced by hydrocortisone and epinephrine in circulating myeloid progenitor cells (CFU-GM) in man.
Morra L; Ponassi A; Caristo G; Bruzzi P; Bonelli A; Zunino R; Parodi GB; Sacchetti C
Biomed Pharmacother; 1984; 38(3):167-70. PubMed ID: 6541067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
